Marina A. Malikova, PhD, MSci, MACI, MBA, RAC

Assistant Professor, Boston University Chobanian & Avedisian School of Medicine

Biography

Dr. Malikova graduated from the Institute of Biochemistry, Russian Academy of Science, in Moscow, Russia with a PhD in Biochemistry. She has a strong background in biomedical sciences and has completed her postdoctoral fellowship in the field of cell signaling and cell migration. She also holds a Master’s Degree in Clinical Investigation and Project Management Certification from Boston University.

In her current role as Executive Director, Dr. Malikova manages research efforts in seven divisions of the Department of Surgery at Boston Medical Center. She is responsible for clinical trials and basic biomedical research operations, risk management, strategic planning, and macro-management of research programs. She provides guidance and oversight to the Project Managers, Clinical Research Associates (CRAs), Clinical Research Coordinators (CRCs), and laboratory staff. She also provides assistance to investigators with protocol and informed consent writing, regulatory submissions, clinical trial agreements and budget development.

Publications

  • Published 5/1/2025

    Joyce NP, Coker D, Volansky V, Malikova MA. Risk-based safety and quality management strategies in wound care trials at a tertiary, safety net hospital. J Wound Care. 2025 May 01; 34(Sup5):S34-S44. PMID: 40358500.

    Read at: PubMed

  • Published 4/1/2025

    Joyce NP, Vazirani A, Roddy C, Malikova MA. Effect of social determinants of health on clinical trials conducted for diabetic foot ulcer and venous leg ulcer at a safety net hospital. Wounds. 2025 Apr; 37(4):158-165. PMID: 40368391.

    Read at: PubMed

  • Published 2/19/2025

    He Y, Wei G, Greene T, Imrey PB, Northrup H, Radeva MK, Beck GJ, Gassman JJ, Kraiss LW, Robbin M, Roy-Chaudhury P, Cheung AK, Berceli SA, Shiu YT. Hemodynamics are associated with subsequent lumen remodeling and clinical maturation of hemodialysis arteriovenous fistula. Sci Rep. 2025 Feb 19; 15(1):6131. PMID: 39972115.

    Read at: PubMed

  • Published 9/1/2024

    Lotfollahzadeh S, Vazirani A, Sellinger IE, Clovie J, Hoekstra I, Patel A, Malloum AB, Yin W, Paul H, Yadati P, Siracus J, Malikova M, Pernar LI, Francis J, Stern L, Chitalia VC. Aryl Hydrocarbon Receptor Pathway Augments Peritoneal Fibrosis in a Murine CKD Model Exposed to Peritoneal Dialysate. Kidney360. 2024 Sep 01; 5(9):1238-1250. PMID: 39235862.

    Read at: PubMed

  • Published 5/29/2024

    Bathla T, Lotfollahzadeh S, Quisel M, Mehta M, Malikova M, Chitalia VC. End Organ Affection in Sickle Cell Disease. Cells. 2024 May 29; 13(11). PMID: 38891066.

    Read at: PubMed

View All 89 Publications:   View Full Profile in BUMC

Other Positions

  • Executive Director, Surgical Translational Research Operations and Compliance
    Boston University Chobanian & Avedisian School of Medicine

Websites

View all profiles